Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23977 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.21574 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.21908 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.16544 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.16781 | 9 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.27295 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.23307 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.19609 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.18708 | 9 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.20686 | 9 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.20281 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.19011 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.21168 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.20794 | 9 |